外周血淋巴细胞/单核细胞比值与恶性胸膜间皮瘤患者预后的关系
Correlation between lymphocyte-to-monocyte ratio in peripheral blood and prognosis of malignant pleural mesothelioma

DOI: 10.6040/j.issn.1671-7554.0.2016.355

Keywords: 总生存期,胸腔镜,淋巴细胞/单核细胞比值,恶性胸膜间皮瘤,预后,
Thoracoscopy,Lymphocyte-to-monocyte ratio,Malignant pleural mesothelioma,Prognosis,Overall survival

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Nishijima TF, Muss HB, Shachar SS, et al. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A systematic review and meta-analysis[J]. Cancer Treat Rev, 2015, 41(10): 971-978.
[2]	Coussens LM, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917): 860-867.
[3]	Schmidt H, Bastholt L, Geertsen P, et al. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model[J]. Br J Cancer, 2005, 93(3): 273-278.
[4]	Lee YY, Choi CH, Sung CO, et al. Prognostic value of pretreatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level[J]. Gynecol Oncol, 2012, 124(1): 92-97.
[5]	Koh YW, Shin SJ, Park C, et al. Absolute monocyte count predicts overall survival in mantle cell lymphomas: correlation with tumour-associated macrophages[J]. Hematol Oncol, 2014, 32(4): 178-186.
[6]	Chanmee T, Ontong P, Konno K, et al. Tumor-associated macrophages as major players in the tumor microenvironment[J]. Cancers, 2014, 6(3): 1670-1690.
[7]	曲宸绪, 周珊珊, 乔友林. 我国部分地区胸膜间皮瘤的描述流行病学分析[J]. 肿瘤研究与临床, 2004, 16(2): 143-144.
[8]	Cao C, Tian D, Park J, et al. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma[J]. Lung Cancer, 2014, 83(2): 240-245.
[9]	Rusch VW. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group[J]. Chest, 1995, 108(4): 1122-1128.
[10]	郭靓, 钱露, 郭宁. 炎症——肿瘤恶性演进的推手[J]. 中国肿瘤生物治疗杂志, 2013, 20(3): 259-265. GUO Liang, QIAN Lu, GUO Ning. Inflammation: A promoter in malignant progression of tumor[J]. Chin J Cancer Biother, 2013, 20(3): 259-265.
[11]	Li ZM, Huang JJ, Xia Y, et al. Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP[J]. PLoS ONE, 2012, 7(7): e41658. doi: 10.1371/journal.pone.0041658.
[12]	Hu P, Shen H, Wang G, et al. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: based on a large cohort study[J]. PLoS ONE, 2014, 9(9): e108062. doi: 10.1371/journal.pone.0108062.
[13]	张盼, 王静. 胸膜间皮瘤的研究进展[J]. 肿瘤基础与临床, 2011, 24(1): 81-82.
[14]	Porrata LF, Ristow K, Colgan JP, et al. Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkins lymphoma[J]. Haematologica, 2012, 97(2): 262-269.
[15]	Zhou X, Du Y, Xu J, et al. The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage Ⅱ/Ⅲ gastric cancer[J]. Tumour Biol, 2014, 35(11): 11659-11666.
[16]	Lin GN, Peng JW, Xiao JJ, et al. Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet[J]. Med Oncol, 2014, 31(7): 70.
[17]	Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-444.
[18]	Stotz M, Szkandera J, Stojakovic T, et al. The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer[J]. Clin Chem Lab Med, 2015, 53(3): 499-506.

Full-Text